Cargando…

Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer

BACKGROUND: Pancreatic ductal adenocarcinoma is one of the leading causes of cancer-related death worldwide. Immune checkpoint blockade therapy, including anti-PD-1 and anti-PD-L1, is a new therapeutic strategy for cancer treatment but the monotherapy with PD-L1 inhibitors for pancreatic cancer is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Ping, Zhao, Jingyuan, Meng, Zibo, Wu, Heyu, Wang, Bo, Wu, Heshui, Jin, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359760/ https://www.ncbi.nlm.nih.gov/pubmed/30709380 http://dx.doi.org/10.1186/s13046-019-1044-z

Ejemplares similares

Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
por: Sun, Yan, et al.
Publicado: (2021)

FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma
por: Wang, Bo, et al.
Publicado: (2018)

The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
por: Meng, Zibo, et al.
Publicado: (2020)

Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway
por: Ren, Dianyun, et al.
Publicado: (2019)

Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway
por: Liu, Zhiqiang, et al.
Publicado: (2020)

Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma
por: Meng, Zibo, et al.
Publicado: (2020)

Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway
por: Wu, Shihong, et al.
Publicado: (2022)

Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Meng, Zibo, et al.
Publicado: (2019)

Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitis
por: Zhang, Yushun, et al.
Publicado: (2017)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
por: Trisciuoglio, Daniela, et al.
Publicado: (2018)

KAT5 histone acetyltransferase mutations in cancer cells
por: L Hardison, Kimberly, et al.
Publicado: (2022)

And-1 is required for the stability of histone acetyltransferase Gcn5
por: Li, Yongming, et al.
Publicado: (2011)

Structure of Patt1 human proapoptotic histone acetyltransferase
por: Jędrzejewski, Roch Paweł, et al.
Publicado: (2013)

The Role of Histone Acetyltransferases and Histone Deacetylases in Photoreceptor Differentiation and Degeneration
por: Zhao, Meng, et al.
Publicado: (2020)

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
por: Chowdhury, Subrata, et al.
Publicado: (2016)

Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
por: Kim, Ji-Hyun, et al.
Publicado: (2019)

Programmed death-ligand 1 expression in rectal cancer
por: Jomrich, G., et al.
Publicado: (2016)

Platelet Distribution Width Levels Can Be a Predictor in the Diagnosis of Persistent Organ Failure in Acute Pancreatitis
por: Wang, Feiyang, et al.
Publicado: (2017)

Snail acetylation by histone acetyltransferase p300 in lung cancer
por: Chang, Rui, et al.
Publicado: (2017)

Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer
por: Liu, Xiaojun, et al.
Publicado: (2016)

No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
por: Campbell, Ian G, et al.
Publicado: (2004)

Histone Acetyltransferases in Plant Development and Plasticity
por: Boycheva, Irina, et al.
Publicado: (2014)

Histone Acetyltransferases and Stem Cell Identity
por: He, Ruicen, et al.
Publicado: (2021)

Colonic Gastrointestinal Stromal Tumor: A Population-Based Analysis of Incidence and Survival
por: Liu, Zhiqiang, et al.
Publicado: (2019)

Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis
por: Liu, Zhiqiang, et al.
Publicado: (2019)

Effects of caffeine on cell viability and activity of histone deacetylase 1 and histone acetyltransferase in glioma cells
por: Chen, Jin-Cherng, et al.
Publicado: (2016)

Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
por: Joneja, Upasana, et al.
Publicado: (2017)

Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide
por: Hong, Zhe, et al.
Publicado: (2021)

B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis
por: Meng, Zibo, et al.
Publicado: (2017)

Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer
por: Purwanto, Ibnu, et al.
Publicado: (2020)

Correction: B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis
por: Meng, Zibo, et al.
Publicado: (2018)

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer
por: Park, Hyunkyung, et al.
Publicado: (2019)

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer
por: Imai, Daisuke, et al.
Publicado: (2017)

Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression
por: Zheng, Nan-Nan, et al.
Publicado: (2020)

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
por: Yang, Hanshen, et al.
Publicado: (2022)

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer
por: Zhou, Yingke, et al.
Publicado: (2022)

Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer
por: Wang, Shiqiang, et al.
Publicado: (2020)

The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression
por: Guo, Renbo, et al.
Publicado: (2022)

The Role of p300 Histone Acetyltransferase in UV-Induced Histone Modifications and MMP-1 Gene Transcription
por: Kim, Min-Kyoung, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ecnp42dgtlij8p2usph9l2n3rp